Sadeghzadeh M, Bornehdeli S, Mohahammadrezakhani H, Abolghasemi M, Poursaei E, Asadi M, et al. Dendritic cell therapy in cancer treatment; the state-of-the-art. Life Sci. 2020;254:117580.

Article  CAS  PubMed  Google Scholar 

Ghorbaninezhad F, Masoumi J, Bakhshivand M, Baghbanzadeh A, Mokhtarzadeh A, Kazemi T, et al. CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro. Front Immunol. 2022;13:931316.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gardner A, de Mingo PÁ, Ruffell B. Dendritic cells and their role in immunotherapy. Front Immunol. 2020;11:924.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gallois A, Bhardwaj N. Dendritic cell-targeted approaches to modulate immune dysfunction in the tumor microenvironment. Front Immunol. 2013;4:436.

Article  PubMed  PubMed Central  Google Scholar 

Anguille S, Smits EL, Lion E, van Tendeloo VF, Berneman ZN. Clinical use of dendritic cells for cancer therapy. Lancet Oncol. 2014;15(7):e257–67.

Article  CAS  PubMed  Google Scholar 

Veglia F, Gabrilovich DI. Dendritic cells in cancer: the role revisited. Curr Opin Immunol. 2017;45:43–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Domogalla MP, Rostan PV, Raker VK, Steinbrink K. Tolerance through education: how tolerogenic dendritic cells shape immunity. Front Immunol. 2017;8:1764.

Article  PubMed  PubMed Central  Google Scholar 

Morante-Palacios O, Fondelli F, Ballestar E, Martínez-Cáceres EM. Tolerogenic dendritic cells in autoimmunity and inflammatory diseases. Trends Immunol. 2021;42(1):59–75.

Article  CAS  PubMed  Google Scholar 

Alipour S, Kazemi T, Sadeghi MR, Heris JA, Masoumi J, Naseri B, et al. Glyburide-treated human monocyte-derived dendritic cells loaded with insulin represent tolerogenic features with anti-inflammatory responses and modulate autologous T cell responses in vitro. Int Immunopharmacol. 2024;126:111230.

Article  CAS  PubMed  Google Scholar 

Dudek AM, Martin S, Garg AD, Agostinis P. Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front Immunol. 2013;4:438.

Article  PubMed  PubMed Central  Google Scholar 

Jensen SS, Gad M. Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity. J Inflamm. 2010;7:1–12.

Article  Google Scholar 

Said A, Weindl G. Regulation of dendritic cell function in inflammation. Journal of immunology research. 2015;2015.

Liu J, Zhang X, Cheng Y, Cao X. Dendritic cell migration in inflammation and immunity. Cell Mol Immunol. 2021;18(11):2461–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghahramanipour Z, Alipour S, Masoumi J, Rostamlou A, Hatami-Sadr A, Heris JA, et al. Regulation of dendritic cell functions by vitamins as promising therapeutic strategy for immune system disorders. Advanced Biology. 2023;7(12):2300142.

Article  CAS  Google Scholar 

Švajger U, Rožman P. Tolerogenic dendritic cells: molecular and cellular mechanisms in transplantation. J Leukoc Biol. 2014;95(1):53–69.

Article  PubMed  Google Scholar 

Sohrabi S, Masoumi J, Naseri B, Ghorbaninezhad F, Alipour S, Kazemi T, et al. STATs signaling pathways in dendritic cells: as potential therapeutic targets? International Reviews of Immunology. 2023:1–22.

Sun X, Pang H, Li J, Luo S, Huang G, Li X, et al. The NLRP3 inflammasome and its role in T1DM. Front Immunol. 2020;11:1595.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ganguly D, Haak S, Sisirak V, Reizis B. The role of dendritic cells in autoimmunity. Nat Rev Immunol. 2013;13(8):566–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gris D, Ye Z, Iocca HA, Wen H, Craven RR, Gris P, et al. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol. 2010;185(2):974–81.

Article  CAS  PubMed  Google Scholar 

Kim CW, Kim K-D, Lee HK. The role of dendritic cells in tumor microenvironments and their uses as therapeutic targets. BMB Rep. 2021;54(1):31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Castro LF, Longhi LNA, Paião MR, da Silva Justo-Júnior A, de Jesus MB, Blotta MHDSL, et al. NLRP3 inflammasome is involved in the recognition of Paracoccidioides brasiliensis by human dendritic cells and in the induction of Th17 cells. J Infection. 2018;77(2):137–44.

Omosun Y, McKeithen D, Ryans K, Kibakaya C, Blas-Machado U, Li D, et al. Interleukin-10 modulates antigen presentation by dendritic cells through regulation of NLRP3 inflammasome assembly during Chlamydia infection. Infect Immun. 2015;83(12):4662–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011;12(1):21–35.

Article  CAS  PubMed  Google Scholar 

Powell JD, Pollizzi KN, Heikamp EB, Horton MR. Regulation of immune responses by mTOR. Annu Rev Immunol. 2012;30:39–68.

Article  CAS  PubMed  Google Scholar 

Mills RE, Jameson JM. T cell dependence on mTOR signaling. Cell Cycle. 2009;8(4):545–8.

Article  CAS  PubMed  Google Scholar 

Weichhart T, Säemann MD. The multiple facets of mTOR in immunity. Trends Immunol. 2009;30(5):218–26.

Article  CAS  PubMed  Google Scholar 

Jones RG, Pearce EJ. MenTORing immunity: mTOR signaling in the development and function of tissue-resident immune cells. Immunity. 2017;46(5):730–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Howell JJ, Ricoult SJ, Ben-Sahra I, Manning BD. A growing role for mTOR in promoting anabolic metabolism. Biochem Soc Trans. 2013;41(4):906–12.

Article  CAS  PubMed  Google Scholar 

Morita M, Gravel S-P, Hulea L, Larsson O, Pollak M, St-Pierre J, et al. mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle. 2015;14(4):473–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mafi S, Mansoori B, Taeb S, Sadeghi H, Abbasi R, Cho WC, et al. mTOR-mediated regulation of immune responses in cancer and tumor microenvironment. Front Immunol. 2022;12:774103.

Article  PubMed  PubMed Central  Google Scholar 

Chen W, Ma T, Shen X-N, Xia X-F, Xu G-D, Bai X-l, et al. Macrophage-induced tumor angiogenesis is regulated by the TSC2–mTOR pathway. Cancer Research. 2012;72(6):1363–72.

Article  CAS  PubMed  Google Scholar 

Fukao T, Tanabe M, Terauchi Y, Ota T, Matsuda S, Asano T, et al. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat Immunol. 2002;3(9):875–81.

Article  CAS  PubMed  Google Scholar 

McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells Blood. J Am Soc Hematol. 2000;95(11):3489–97.

CAS  Google Scholar